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to provide pa5CIII protection for jHDI:CISCS
and products relating to pharmaceulicals.'
The.e include proteclion fDr phonnl<.ulicol
compositions, tbcrapeulic ...... , polymorph.,
active: ingrccIicnts related forms and pIwma-
CCUIicaJ II"' " .
Mill)' de>cIoping c:ouatria have: 0b-
jected to the iadIrsion of pateftl proIOCbon
for pbannaceuIic:aI willlin tbc W10 frame-
work for Ibrec primary 1'C8IOIIS. First. IORII!
devclopina countries believe dUll ace ...1 10
medicine. is a human riJbl.' They worry thai
prolection will restrict acce •• 10 _nti.1
medic:ine•. • Second. some view protcction
for pbannaccutic:al puenu as unfair. Some
developinl counttics DOIaIIhBImay devel-
oped counttics refused 10 procea imeJloc:tuaI
jHupelIy riJhu IIIIfficieudy wben protectioll
was IlOlin tbeirbcst ccunomic intercau -such
.. whcn Netherlands did DOCprovide ""tcol
proleclion during the I 'l'" ccolury. 'Third, il is
general. ....y scholafll now USC thai tam
in other areas or law, includi"l! intellectual
propeny law.' The .«Iusi.e rigbt given 10
an owner uf intolleclual propeny 10exclude
olh_ from lISinl dUllpropeny appeanlo fit
with HeUer'. dcsc:ripIioII. All exclusive riabt
olk:n aatellClllioa bet>oecndie_II1II
_mIIaS 0( society wlMloe __ 10 tbc in-
lell«tual jHupelIy becOlllO. IimiIOd by law.
The t.... ioII between pri.... e OWlICfc
ship rights and public access i.a key feBiurc
of pluum""eutil:81 palents. Protection for
medicines, il is "Sued. i. likely 10 .ffecl ac-
cess to medicine. for pcuplc in developina
countrics. Both before IIId after die TRIPS
Agreemeill. plwmacculicaJ palen! proICe.
bon ..... been • controvenial issue .. ithin
8 IIUIIIber 0( c:cumries.' In particular. in tbc
pclSl TRIPS era. palall protcclion for DICdi-
cines h.. beco a cuncom amongst WTO
members because TRIPS require. members
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and policies of South African government in
handling the impact of pharmaceutical pat-
ent on 10 essential medicines has lessons for
other developing countries. For example, the
South African government succeeded in ap-
plying compulsory license and parallel im-
port policies to providing cheaper drugs for
HlV/AIDS patients.12
This chapter will discuss the national
dNg policies in South Africa both hefore .
and after the TRIPS Agreement and the
problems tIIat arise because of the patent
system, panicularly phannaceulical patent
protection, One example oflension faced by
the South African government due 10 phar-
maceutical patent protection is the conflict
hetween government efforts to provide af-
fordable HIVIAIDS drugs 10 South African
public and • pressure from multinational
pharmaceutical companies, which criticize
the insufficient protection of pharmaceutical
patents in South Africa,
often argued Ibal proteenon will hamper the
development of local pharmaceutical com-
panies in developing countries upon which
increasing access to medicines.' These con-
cerns are understandable because a number
of studies have shown that patent protec-
tion for phannaceuticals increases !he price
of drug. in developing countries. I.Higher
prices limit the access oflbe public, particu-
larly !he poor, to cheaper drugs." Reduced
access to important medicines has caused
much conflict in many developing countries.
including S<Ju1bAfrica.
South Africa is suffering from the regu-
lations that protect pbamw:cutical pa_
under the TRfI'S Agreement of the WTO.
Polari7Jed positions between providing suf-
ficient protection for pharmaceutical pat-
ents accordillg to international staDduds
of TlUPS and providing affordable dJup
to their societies are challenge. facing the
South African government. The experience
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nalionll drug policy bepn ilL South A£rica
prior 10 Ibe TRIPS AgJeeI1Ient. During iLS
cady period of iDdependence,South Africa
had • modem pateDI law through the South
African hIeata.Designs, Trade Marks and
Capyript Act 0( 1916." Since tILe 19SOs,
seven! ......... after its ;Mcre'*_,
SoudL Alrica ILad • 1181*-1 paICDI syIIeIIL
UDder tILe SaudI Mri<:an ,._ Law 0( 1952.
SouthA£rica baa puticip.kd in mullilalcral
IP recuJatiou siam 1947 u • member orlbe
Puil Convention" and !hen as member uf
Mvera! muitilELlenLlagreemeoll, .""h as lhe
Pa_ Coopenrioa Treaty (PCT), tILe Bulla·
pes! Tnaly and TRIPS.17 Hoc surpriliDgIy,
ftam the iDdicaIun of iIs compI~ with
iDlalLRwI........ of iaIeIIecIuaI .....
erty repIIIioD, SoaIh A£rica _ nabdtILe
.,.._ IP prI)IeCIiw: _, Il1IOIII otILer
dew:1opiJL& COILIIIries. nThis ........ 1.tbiI
country 10bave • strong patent system.It
Why did a develupiD. country like
Soutb A£rica chooee a strollS patent I)"SIem
foIlowin. its il""I*I''''" ..? This is • very
crucia1 ~ because durin& the 19401
and Ihe 19S00 otILer deoelopiac __
decided 10 adopl a weak pelCIIl syIIeIIL or DO
pIIeLLI system 11oil"
1. PIIal1LUCfttlcalpat •• t prtLI:eetIotL
._._ _ ...... .., paIIC)" beflLft
tile TRIPS ~:W&I.t (1932-1993)
SoadL A£rica piJLed -1' ......ill
1932 from BriIiIIL pMI_LII.M an ex
colony of BriIillL nile, SaudI Afiiea hid a
similar petaLt .,_ 10 tILe pre 1999· I....
dian S)'SleltI." However, IOL1le partS of ill
history, such as apartheid systems in etfect
until 1993 were differeD! from India. India
had a more developed domestic pharmaccI>-
ticaJ indua1ry" COIIIp8Rd IU the SuudL Af-
rican pbormoLccuIicaI induIuy (Ibis will he
disa II:~ilL deIaiJ below). HisIuric:aIly, the
iDIeIreIaIiun betvoeen paICDI prDIectioD and
8. TIle 1HJIe. Betw_ 1_1I8tioii.1
SURdanll Md Domntle Develop-
menflll Policy ,. Seuth AfrIc. - A
Cue Stud)": Tile PoUC)"of M .... eml
TIle HIV ... AIDS By C•• p"_"
u.- aM hnDlllapcwts
This s"hchoptcr clisalll II the impKt of
pbarmao:euIicaJ pIICLIII pruIIICIi ... OD access
10 eSI :LIIial medicines ilL SouIb Africa. 10
puticuJar, tILe discusaion focuses OD c0m-
pulsory license and paraUel import issues
before ami ELfIerthe TRIPS Acreement.
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multinational companies to invest and estab-
lish manufacturing subsidiaries in its phar-
maceutical sector. This foreign direct invest-
ment in South Africa continued to increase
unlil 1960-19705." Apart from plllent sys-
tem, the existence of the rich white people
in urban IIIC8S witb the higil-<luality facilities
develOPed during the apartheid era" created
• profitable market for atlrlK:ting multina-
tiooal pbarmaeeutical companies coming to
South Africa.
The adoption uf an advanced patent sys-
tem, however did DOl continue to attract for-
eign investment in South Africa after 19705
because most countries disagreedwith apan-
heid in South Africa. Some countries, such
as Japan, blll!led their citizens from iovest-
iog their capital in South Africa."
The 9IIOIl8 patenl suucture brought
new problems ODpublic heallh secIOrs dur-
iog the apartheid ..... The Suyman Commis-
siODin 1962 for example, raised the issue of
the impact of patent on drug prices in South
Africa: ''[p]alCDlS maintain drug prices al too
high levels and for unneoessarily long peri-
ods."" In 1975, the Steekamp Commission
proposed applying compulsory liceDses due
to ovctpricing of drul!" and recommended
introducing aDd maintaining price control in
South Afric a, In 1985, Brown Commission
There seem 10 be al least two reasons
why this country decided to provide a strong
patent system prior TRIPS. First, the ~-
beid system adopted by the South African
Governmenl provided the motivatiOD to par-
ticipate in the international IP agreements
aDd an advanced patent system. Since apart-
heid system was heavily criticized by many
countries, South Africa was practically iso-
lated from the intcmatiooal world. To reduce
its isolation, South Africa altcmpted 10 bring
its regulatiu"", iocluding pateot law io ac-
cordance with international standards. This
is also a way of proving that the apartheid
system does not inftuence South Africa's
obligation in complying with international
standards aDd is a legacy of Apartheid."
Second, it is claimed that an advanced
patent system wiU help altmCt Con:ijpl direct
iovestment. Historically, South Africa is
an experienced country in terms of CoreigII
direct investmeDt. Since the I92Os,·most
foreign investors fromUK, US and Europe
were invested their capital in So"th Africa,
particularly in mining sectors." To altmCt
more foreign investors to come to South M-
rica, the Government adopted an advanoed
patent system. Before 1950, South Africa
was among few developing countries which
could attract the US largest pharmaceutical
~ /W_p.ll.5_
~ tw.
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for lIle Soulh African public. tbey were nev-
er implemented by tbe Governmenl. IIGiven
Ibole fletl, Ih. adoption of liron. patenl
sySlCtn and lack of a comprehensive national
drua policy under Ihe apartheid syllem are
Ihe maiD _ oflhe publeml in Ihe public
health _ Tbcae also caused Ihe Govern-
ment'l reluetaace 10 follow up -
meodatiCIII ftom diose commissioos.
Prior to TlUPS, a strong pelCIII syaIem
adopted by the Soulb African Government
belped maintain a monopoly and favored
multinational phamw:eutical dNIII. II i.
evident lbat during Ihe 1960110 1980., Ihe
Soudt African pIJarmaceuticaI compIIIlICI
8Cbievcd _ impcssive pcrformuce in
_ 01JIftI6IID1 JI",dllclioo. By -.
_ 10 cIIeapcr dNp for __ poor .-.
pie &am diaadvatoged poupI .... limited.
Similarly, dtlO10 Ihe opartbeid s)'IIem, the
poor in South Africa were treated unfairly.
Ourinc Ihe 1940., the application of health
policy and plllllliDgwas iDIlueacld by polit-
ical COIIIidcntiOD raIher tt.n beaIth crileria
willl the maiD focus ol"satisfyint Ihe aeeds
of !be while population. "" The ponibility
of esubJ.ishiJJc • tmiIary system wu ended
by Ihe Tomlinson RepOI1of 1954 whicb ree-
ommended tbe application of separate race·
based hoallh services for the people in South
Africa." Not surprisingly. health policies
and plamtillCduring apartheid II)'Stem were
found lIlat -Soulh African drug prices an:
excessive ....21
Under the aparlheid system, the gov-
ornment in racl regulated 8(1_ policies to
provide access 10 aft'ordlble drup to its
public as an allempl of '"*""ling Ihe nega-
live impKI of plICal pnJIeCIion. DrugC08IS
COIISIiluledOIl important issue cIurios Ihe
1960s. Slralqies included Ihe esaablish-
ment of a Nalional Medi(ioes RegulatoIy
Bady, a Medicines Control Council (MCC)
and a Centralised DNa Procurement Agen-
cy (COMED)." These policies and several
commissions were set up by tbeGovemmeat
to maDIjlC Ihe problema of public bealth."
These coJlllllipiont adIkeued !he price
ofmediciao:s, ~ ~ oad
beaJth services, pelellllept.ticm MIdJCDCric
drugusc. Boch Ihe SayJDIIl8lld Brown Com-
missions focwoed on peIeD! proIec:tioo dura-
tion, Snyman had ID agenda to provide a
shorter patent prolection instead of 16 years
peat protection. The Brown Commission
suggested shortmiD. Ihe pe_ protectioa
to 14 years. The S......... mp CIlIDIIIissioo
Nt s J Ihe val .. of comptIsofy lic:ease and
the reasons for lpplyiD!llhe Iiceme. Most
iDtc:n:stiusIY, Ihe Stoenbmp Commission
suggested lbat the Government should ban
drug promotion by phartnaeilll, doclors and
denlislS." Even though Ibose recommenda-
tions were very uleful to reduce drug prices
2. P••r.. _1iaI1 p.. eat pretedIH
...,._. ... litmoldnl puIky .Iter til"
TRIPS Acne..... ' (1994 - pnsent)
Tbeendoftbe aputheid..,gime in South
Africa broughI new hope for most South Af-
,;.",.. people. As a cammy which had been
isaIated by the iDIcmatioDaJOOIlIIIlUIIilydue
10 the lIpIFIheid system, Ibc South AfricaD
Go ..... idIl Will !Kedby contIicIiDg dIoic-
cs: should it comply with the iDk:ma1iooal
_standards of Ibc TRIPS Agreement or im-
prove ils public hesIIb scclortbrough dome&-
lie deveIopmcDt pulicy7 011 theOIIC baud. in
onIo:r to cootinue iIs economic dcvelopDeDt
and 10 albacl fon:igo iImosIms, Ibc Govern-
menl perceived that it ucedcd 10bring its in-
I.Ucclual properly laws in line with TRIPS.
On the other band, public bcallh problems,
particularly the mV/AIDS epidemic and Ie-
cess 10 essentia1 drugs. bad become serious
problems for the government. Like India.
Soutb Africa faced difliculties when it at-
tempted 10bring irs palenl law into campli-
duee legislation. other gwups. sueh as heallh
acllVislS and academics. actively lOOk aCllon
to balance tbe power of the governmenl in
public health seclor. This shiflcd power from
lhe government 10_mb outside the gov-
ernment." During this period. the priorily in
public health prop1UIIS was 10 mlllDl the
drug sector by focusilll Oft universal access
10 primary heslth .........
... AndyGmyctal.op. cu..p. 11.
" rnlC Oepaab.....ut of Health. op.,·il .• p. 10.
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piecemeal and nOl framed in a comprehen-
sive drug policy."
During the 1980.. "a high degree of
fragmenlalion in tbe health services and
policies co-otdination" CODlinued 10 be ap-
plied by the government tbrough irs h0me-
land policy and Tricamcral syslem of 1983.
South African public health facililies, in-
cluding hospitals were ""II"'1I"ted belweeD
while and DOD-wbilccilms."
During 1989 to 1990. the government
attempted 10 improve public heallb _ by
desegregating the use of public facililies and
changing il with income differeotials based
a dual system. Due to the misdiSlributioo of
public lilcililics, most public fiIciIities pr0-
vided by the govClDlDCDl were inllCCClSiblc
for the popuJation that was entitled 10 .....
lhem. Similarly, savices and pc:IlIDIIDd _"
less available for the "low income and SJOcio..
ccooomicaUy dcpriYCd communili""W wuIa'
the new system."
In order to improve !he public health
seclOr, the GovCIDIIICIII attempted 10 ..,gu-
lale several policies and legislations under
the apartheid era, sudt as prioritizilll drug
sector refotm during 1989 - 1994." When
!he .parIheid systCIII. whicb influenced the
development of public bealth seclor in Soutb
Africa, ended in 1993. policy in the public
bealtb sector was impacted by new political
factors. While the Governmenl <'ODlinucd 10
formulatc public h •• 11b policies and to pro-
• Sn! ...... A8ML.1IIcIlP.-" t of"""PS~forOl.' " cc~... ,,...
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realize tIIJJ goal, !he Souch AfricaD goyero-
man eslabli.becI a ,;oiDI company which eee-
sists of CIPLA and local companies, called
Cipla-Mcdpro to produce AIDS drugs, such
.. Zidovudine, Stavudinc ad Lamivudinc
iD SouIhAIhca..,
Many pharmaceulical companies ob-
jected to this policy, arguing lhat it violates
Article 27 of the TRIPS Apecmcnl South
Africa jllllifies this policY J>ea.... of lite
IIIII1II:ter of HIVIAIDS infected poopIc in this
COUDtry, recorded as lite highest rate iD lhe
world." By 2005, cxperIS predict thai "over
tbrcc miUioII SouIhA&ic_ will have died
Iium AieII.....E_ ........ dIae lie sewnI
pharmaceulical prodw:lI thai ore availablc
on the IDIrket for curine HIV/AIDS, mOil
poopIc ill SouIh Africa .- buy tbc drup
bet .... tbcy _ ¥CIY cxpcmivc."
The _ iDIeoesliD& IIIilI& is thai tbc
South African governmenl had DeVer c_
gorized HIVIAIDS ... nMiooaJ elllClJCllCY
cw .... compuIsoIy ~ iD order "10
pruduce ..,.nccqJieI 0(_ y m I;'.
tioDs to lint HIV/AIDS....' Many obsa.m
argue thai !he govenunenl is afraid of trlde
saoctiOlll trom induslrialiad countries. par-
ticularly tbc UDited StaII!s ad olber A lIern
....-MI.• In 1998,The Uoilcd Stated criti-
cized the Medicines Act of 1997 in Soulh
IDa:willt!he TRIPSAai--- .
To solve !hose pooblnns, in the poll
apanheid era the Government fonnulall!d
IICveta! policies in public beallIt, illCludinl
1M DMioaaIdrug policy (1994-1996), ...
IiInniug mediciDcs COIItIollcgilWioa (1996-
1999)ad plelWing the CSSCSItiai drugs lilt
(1995-1999)."
Reformins modicinca COIIIroI ...
tion illushlcs the leDSion bet ..... iDtcr·
IIIIioDaI II8ndards of pbumaccutical pII-
CDI protection ad domestic developmental
policy. In 1997, tbrcc )'UrI after the TRIPS
...._"'111 ",u t.uncbcd, the Soudt A&ic:an
JIO.ClINI ...... enacted the Mediciws ad R.e-
I8IrJd SubIIaDc:cs Control Amendment Ad
(Medicines ACI).This coDlrovenial act per-
mits penUel importalioo and ~
ticmsiDl (article IS C) dcUag wi1b .....
JIIKaIIic:aI products. Under article IS c, tbc
Mini~ of Hea111tbas the power 10 coolrol
lhe a'YBilabililyof cheaper drup by permil-
tiDg 0II0Iher ron.-"y, GIber .... ........
hoIcIcr, 10 pruduce its ..... (i.e. campuIJory
license)."
The main Coal of lite McdiciDcs Act
is 10 facilitate imponina c1lapcr aDd aood
quality HlV/AlDS drup ftaD GIber CGUII-
Irics ... 10 provide IIimulaIioa lOr produc-
ing !hose dru.. inSouth Africa. In order 10
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Due to political pressures from the gov-
ernments of developed countries, tbe USA
in particular. controversial section I S (c) of
the Medicines Act of 1997 was amended in
2002. The Parallel Importation Act in phar-
maceuticals in Soutb Africa was adjUSted to
the TRIPS standards and now fulfils the ex-
pectation of multinational companies. These
are the requirements for parallel importation
of plwmaceutical products in Soutb Africa
according to the Medicines Act of2002:
I. The: importer should get a permit from
!he government before importing the
products (Article 22 A (118»;
2. The import permit may be refused if
it does not meet the criteria of tbis act,
including lack of capability of keeping
and to sioring the substance or medi-
cines in a satisfactory manners (article
22 A (lIc»;
3. The import permit must be valid during
tbe importation (Article 22A(lle»
4. The imported products are controlled
by the governmenl (Article 22 A (12
a.b)."
The South African parallel import regu-
lation fairly considers the interest of patent
bolders. An example is that the application
of paraUel importation in South Africa is
strictly controlled by the Government. An-
other r<:8SOD is that the importer must hold a
valid pennit from the Government 10 import
pharmaceutical products to South Afric a, It
Africa, arguing that the Act did not provide
sufficient protection to pharmaceutical prod-
ucts. Following this c-riticism, the US gov-
ernment put South Africa on a watch list,
along with other countries which failed to
provide sufficient protection 10 intellectual
property. In 2001, the US removed SoulhAf-
rica from the Watch list on the grounds that
"the United States will not initiate sanctions
against developing countries combating the
AlDS epidemic ...••
Even though the decision of the US
government seems to help the South African
government to handle the problem of the ep-
idemic HIV IAIDS disea se, the policy does
not solve Ibe main problems of the South
African government. First, the US policy
was only about removing South Africa from
the watcb list. bot it did oot help !he country
to find a solution to inlemal problems bow
to provide cheap drugs to the South Afri-
can people. Second, even though tbe South
African govenunent successfully induced
"service of its market by generic manufac-
turers"", the South African government
does not have a functioning infiastructure
for providing cheaper drugs to its citizens as
in India. Before the TRIPS Agreement era,
the government did not facibtate the produc-
tion role of local pharmaceutical companies.
Therefore, during the HIV IAIDS epidemic
the South African government imported raw
pharmaceutical materials from India.~'
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